N-Boc-3-bromo-6-chloroindole

Catalog No. :
ACTQPU485
CAS No. :
1246471-36-2
Molecular Formula :
C13H13BrClNO2
Molecular Weight :
330.61

IUPAC Name:tert-butyl 3-bromo-6-chloro-1H-indole-1-carboxylate

N-Boc-3-bromo-6-chloroindole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$100.00Login to see priceIn stockInquiry
10g97%$177.00Login to see priceIn stockInquiry
25g97%$353.00Login to see priceIn stockInquiry
100g97%$1183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Boc-3-bromo-6-chloroindole
IUPAC Nametert-butyl 3-bromo-6-chloro-1H-indole-1-carboxylate
MDL No.MFCD17169908
Molecular FormulaC13H13BrClNO2
Molecular Weight330.61
SMILESClC1=CC2=C(C=C1)C(Br)=CN2C(OC(C)(C)C)=O
InChI KeyBZZPVBVOSNRGHB-UHFFFAOYSA-N
SynonymN-Boc-3-bromo-6-chloroindole | 1246471-36-2 | 3-bromo-6-chloro-1h-indole-1-carboxylic acid tert-butyl ester | TERT-BUTYL 3-BROMO-6-CHLOROINDOLE-1-CARBOXYLATE | MFCD17169908 | 1H-Indole-1-carboxylic acid, 3-bromo-6-chloro-, 1,1-dimethylethyl ester | SCHEMBL23330476 | DT
CAS No.1246471-36-2
PubChem CID73012615

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTQPU485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTQPU485 route product structure diagram
    ACTQPU4851246471-36-2 In Stock
Inquiry

2. ACTQPU485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTQPU485 route product structure diagram
    ACTQPU4851246471-36-2 In Stock
Inquiry

Comments (0)